Forget skincare lines and sneaker drops. According to Rolling Stone's guide to buying GLP-1 medications online, the new celebrity cash cow is weight-loss drugs, and the internet has made them shockingly accessible.
Serena Williams and other high-profile names are now the public faces of GLP-1 medications like Ozempic and Wegovy, transforming what was once a niche diabetes treatment into a mainstream lifestyle choice. Rolling Stone reports that use of these drugs has surged since 2021, with most users now taking them for weight loss rather than managing type 2 diabetes. These medications mimic a natural hormone to regulate appetite and slow digestion.
While online platforms have made obtaining these drugs easier than ever, no traditional doctor visit required, doctors are sounding alarms. Dr. G. Thomas Ruiz, an obstetrician-gynecologist in Orange County, told Rolling Stone: "The problem with online purchases is determining whether the pharmacy is reputable." He flagged serious contraindications, including a history of thyroid cancer, multiple endocrine neoplasia, and inflammatory bowel diseases like ulcerative colitis. Common side effects include GI upset, but gastroparesis, a serious complication affecting stomach function, can develop.
GLP-1 medications have legitimate medical risks, and the rush to democratize access through telemedicine platforms has not solved the vetting problem. A remote consultation does not necessarily include a thorough medical history review. India's growing use of these drugs, fueled by Bollywood and international celebrity culture, mirrors this Western pattern: accessibility without adequate safeguards.
Rolling Stone lists five platforms (Hers, Ro, Noom, Hims, and PlushCare) where you can purchase these drugs online. The publication itself acknowledges the central tension: ease of access does not equal safety. That gap between celebrity endorsement and medical reality deserves attention before anyone clicks "buy now."
